✦ LIBER ✦

Immunocompetent mouse model of breast cancer for preclinical testing of EphA2-targeted therapy

✍ Scribed by Noblitt, Loren W; Bangari, Dinesh S; Shukla, Shruti; Mohammed, Sulma; Mittal, Suresh K

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

231 Efficacy of VEGFR2 targeted mAb ther

✍ D. Surguladze; M.J. Plym; J. Malaby; M. Prewett; M. Rutstein; J. Schwartz; D. Lu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Targeted therapy combos promising for br

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 160 KB

34 Efficacy of VEGFR2 Targeted mAb Thera

✍ Surguladze, D.; Malaby, J.; Prewett, M.; Duignan, I.; Rutstein, M.; Yao, Y.M.; S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Liposomes as Vehicles for Targeted Thera

✍ K.J. Harrington; C.R. Lewanski; J.S.W. Stewart 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Advances in Targeted Therapy for the Pre

✍ Hollander, Petra den; Brown, Powel H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 229 KB

Future directions of bone-targeted thera

✍ Onishi, Tomifumi; Hayashi, Naoki; Theriault, Richard L.; Hortobagyi, Gabriel N.; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 326 KB